↓ Skip to main content

Rituximab for rheumatoid arthritis

Overview of attention for article published in Cochrane database of systematic reviews, January 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter
16 tweeters
wikipedia
1 Wikipedia page

Readers on

mendeley
85 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Rituximab for rheumatoid arthritis
Published in
Cochrane database of systematic reviews, January 2015
DOI 10.1002/14651858.cd007356.pub2
Pubmed ID
Authors

Lopez-Olivo MA, Amezaga Urruela M, McGahan L, Pollono EN, Suarez-Almazor ME, Lopez-Olivo, Maria Angeles, Amezaga Urruela, Matxalen, McGahan, Lynda, Pollono, Eduardo N, Suarez-Almazor, Maria E

Abstract

Rituximab is a selective, B-cell depleting, biologic agent for treating refractory rheumatoid arthritis (RA). It is a chimeric monoclonal antibody targeted against CD 20 that is promoted as therapy for patients who fail to respond to other biologics. There is evidence to suggest that rituximab is effective and well tolerated when used in combination with methotrexate for RA.

Twitter Demographics

The data shown below were collected from the profiles of 16 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 85 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Chile 1 1%
South Africa 1 1%
United Kingdom 1 1%
Brazil 1 1%
Sri Lanka 1 1%
Unknown 80 94%

Demographic breakdown

Readers by professional status Count As %
Student > Master 19 22%
Student > Ph. D. Student 14 16%
Student > Bachelor 10 12%
Student > Postgraduate 10 12%
Researcher 10 12%
Other 22 26%
Readers by discipline Count As %
Medicine and Dentistry 55 65%
Psychology 7 8%
Unspecified 6 7%
Agricultural and Biological Sciences 5 6%
Biochemistry, Genetics and Molecular Biology 3 4%
Other 9 11%

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 May 2017.
All research outputs
#746,563
of 8,650,740 outputs
Outputs from Cochrane database of systematic reviews
#2,916
of 8,707 outputs
Outputs of similar age
#26,528
of 244,508 outputs
Outputs of similar age from Cochrane database of systematic reviews
#92
of 226 outputs
Altmetric has tracked 8,650,740 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,707 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 19.0. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 244,508 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 226 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.